Correction to Advanced Cancer Immunotherapy via SMARCAL1 Blockade Using a Glucose‐Responsive CRISPR Nanovaccine

Concerns were raised by a third party regarding duplication between the third graph and the sixth graph of Figure 4c; however, these graphs depict the same experimental results (the same experimental conditions: GCZH with 1.0 mm glucose).In Figure 5a, the first and second graphs were mistakenly duplicated, and the third and fourth graphs were incorrect.The corrected figure is shown below.This correction does not affect the overall findings and conclusions of this paper.Corrected Figure 5a In Figure 8a, the immunohistochemistry image of PD-L1 in the PBS group was incorrect.The revised figure is provided below.